{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T06:16:24Z","timestamp":1792131384108,"version":"4.4.0"},"reference-count":324,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Life"],"abstract":"<jats:p>Heart failure (HF) remains a leading cause of morbidity and mortality worldwide and is driven by complex, interconnected pathophysiological processes, including maladaptive cardiac remodeling, fibrosis, hypertrophy, metabolic dysregulation, and cardiomyocyte loss. MicroRNAs (miRNAs), small non-coding RNAs that act as key post-transcriptional regulators of gene expression, have emerged as important coordinators of these processes across cardiomyocytes and non-myocyte cardiac cell populations. In addition to altered expression patterns, accumulating evidence indicates that miRNA activity is dynamically influenced by regulated biogenesis, maturation, and context-dependent mechanisms of action. Through reversible translational repression and longer-term mRNA destabilization, miRNAs support adaptive responses to acute cardiac stress, whereas their persistent dysregulation contributes to remodeling pathways that promote HF progression. This comprehensive narrative review provides an integrative overview of current knowledge on the role of miRNA networks in shaping the molecular heterogeneity of heart failure across disease stages, phenotypes, and cardiac cell types. Drawing on a broad body of experimental and clinical literature, we discuss advances in understanding miRNA biogenesis, post-transcriptional control, and cell-specific effects, while highlighting conceptual developments rather than applying systematic selection criteria. We further examine the translational and clinical implications of miRNA biology, critically considering the progress of miRNA-based therapeutics alongside the biological and practical challenges that continue to limit their widespread clinical implementation. In parallel, we explore the emerging potential of circulating miRNAs as minimally invasive biomarkers that reflect upstream regulatory stress at the level of RNA processing and post-transcriptional regulation. Finally, we address the growing application of artificial intelligence and machine learning approaches to high-dimensional miRNA datasets, which enable integrative analyses across clinical, imaging, and multi-omics domains and support biomarker discovery, patient stratification, and prediction of therapeutic response. Collectively, miRNA biology, supported by systems-level and AI-driven analytical frameworks, offers a unifying perspective for understanding, classifying, and monitoring cardiac remodeling in heart failure.<\/jats:p>","DOI":"10.3390\/life16030400","type":"journal-article","created":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T16:06:59Z","timestamp":1772467619000},"page":"400","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["MicroRNAs in Heart Failure Pathogenesis and Progression: Mechanistic Control, Biomarker Potential, and Translational Perspectives"],"prefix":"10.3390","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-0279-6168","authenticated-orcid":false,"given":"Dorotea","family":"Zivalj","sequence":"first","affiliation":[{"name":"Faculty of Medicine, University of Rijeka, 51000 Rijeka, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lou Marie Salom\u00e9","family":"Schleicher","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of Rijeka, 51000 Rijeka, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antea","family":"Krsek","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of Rijeka, 51000 Rijeka, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hadid Joseph Farzad","family":"Diamee","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of Rijeka, 51000 Rijeka, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9743-9201","authenticated-orcid":false,"given":"Damir","family":"Raljevic","sequence":"additional","affiliation":[{"name":"Thalassotherapia Opatija, Clinic for Rehabilitation, Treatment and Prevention of Diseases of the Heart and Blood Vessels, Medical Faculty, University of Rijeka, 51410 Opatija, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2837-4157","authenticated-orcid":false,"given":"Lara","family":"Baticic","sequence":"additional","affiliation":[{"name":"Department of Medical Chemistry, Biochemistry and Clinical Chemistry, Faculty of Medicine, University of Rijeka, 51000 Rijeka, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,3,1]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.cardfail.2021.01.022","article-title":"Universal Definition and Classification of Heart Failure: A Report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure","volume":"27","author":"Bozkurt","year":"2021","journal-title":"J. Card. Fail."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"847","DOI":"10.36290\/vnl.2018.116","article-title":"Diagnosis of Heart Failure: The New Classification of Heart Failure","volume":"64","year":"2018","journal-title":"Vnitr. Lek."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"e07","DOI":"10.15420\/cfr.2024.22","article-title":"History of Heart Failure Definition","volume":"11","author":"Goje","year":"2025","journal-title":"Card. Fail. Rev."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Gavina, C., Carvalho, D.S., Valente, F., Bernardo, F., Dinis-Oliveira, R.J., Santos-Ara\u00fajo, C., and Taveira-Gomes, T. (2022). 20 Years of Real-World Data to Estimate the Prevalence of Heart Failure and Its Subtypes in an Unselected Population of Integrated Care Units. J. Cardiovasc. Dev. Dis., 9.","DOI":"10.3390\/jcdd9050149"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"3272","DOI":"10.1093\/cvr\/cvac013","article-title":"Global Burden of Heart Failure: A Comprehensive and Updated Review of Epidemiology","volume":"118","author":"Savarese","year":"2022","journal-title":"Cardiovasc. Res."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1080\/00015385.2019.1669847","article-title":"sST2 Adds to the Prognostic Value of Gal-3 and BNP in Chronic Heart Failure","volume":"75","author":"Barutaut","year":"2020","journal-title":"Acta Cardiol."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Sciatti, E., Merlo, A., Scangiuzzi, C., Limonta, R., Gori, M., D\u2019Elia, E., Aimo, A., Vergaro, G., Emdin, M., and Senni, M. (2023). Prognostic Value of sST2 in Heart Failure. J. Clin. Med., 12.","DOI":"10.3390\/jcm12123970"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1016\/j.cardfail.2023.07.006","article-title":"Heart Failure Epidemiology and Outcomes Statistics: A Report of the Heart Failure Society of America","volume":"29","author":"Bozkurt","year":"2023","journal-title":"J. Card. Fail."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1002\/ejhf.1858","article-title":"Epidemiology of Heart Failure","volume":"22","author":"Groenewegen","year":"2020","journal-title":"Eur. J. Heart Fail."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"531","DOI":"10.31083\/j.rcm.2020.04.154","article-title":"Epidemiology and Pathogenesis of Heart Failure with Preserved Ejection Fraction","volume":"21","author":"Nair","year":"2020","journal-title":"Rev. Cardiovasc. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"e093306","DOI":"10.1136\/bmjopen-2024-093306","article-title":"Comorbidities and Incidence of Heart Failure with Preserved Ejection Fraction: A Systematic Review and Meta-Analysis of Cohort Studies","volume":"15","author":"Li","year":"2025","journal-title":"BMJ Open"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Winkler, H., Riedlinger, D., Figura, A., Schenk, L., M\u00f6ckel, M., and Reinhold, T. (2025). Characteristics, Health Care Utilization and Cost of Patients Hospitalized with Heart Failure. Front. Health Serv., 5.","DOI":"10.3389\/frhs.2025.1571367"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Chai, R., Xue, W., Shi, S., Zhou, Y., Du, Y., Li, Y., Song, Q., Wu, H., and Hu, Y. (2022). Cardiac Remodeling in Heart Failure: Role of Pyroptosis and Its Therapeutic Implications. Front. Cardiovasc. Med., 9.","DOI":"10.3389\/fcvm.2022.870924"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3892\/mmr.2024.13197","article-title":"Role and Molecular Mechanisms of SGLT2 Inhibitors in Pathological Cardiac Remodeling","volume":"29","author":"Chen","year":"2024","journal-title":"Mol. Med. Rep."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Rolski, F., and M\u0105czewski, M. (2025). Cardiac Fibrosis: Mechanistic Discoveries Linked to SGLT2 Inhibitors. Pharmaceuticals, 18.","DOI":"10.3390\/ph18030313"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/s41569-023-00946-3","article-title":"The Role of the NLRP3 Inflammasome and Pyroptosis in Cardiovascular Diseases","volume":"21","author":"Toldo","year":"2024","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"28195","DOI":"10.31083\/RCM28195","article-title":"Roles of Autophagy, Mitophagy, and Mitochondria in Left Ventricular Remodeling after Myocardial Infarction","volume":"26","author":"Zhang","year":"2025","journal-title":"Rev. Cardiovasc. Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1007\/s00018-025-05793-8","article-title":"Dapagliflozin Alleviates Mitochondrial Damage in the Myocardium under Diabetic Conditions by Targeting Sortilin","volume":"82","author":"Gao","year":"2025","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1186\/s40001-025-02834-7","article-title":"Impact of SGLT2 Inhibitors on Myocardial Fibrosis in Diabetic HFpEF: A Longitudinal Study","volume":"30","author":"Albulushi","year":"2025","journal-title":"Eur. J. Med. Res."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1093\/cvr\/cvaa324","article-title":"Cardiac Fibrosis","volume":"117","author":"Frangogiannis","year":"2021","journal-title":"Cardiovasc. Res."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.jacc.2010.11.013","article-title":"Assessment of Myocardial Fibrosis with Cardiovascular Magnetic Resonance","volume":"57","author":"Mewton","year":"2011","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s00395-013-0357-x","article-title":"Contributions of Cardiomyocyte\u2013Cardiac Fibroblast\u2013Immune Cell Interactions in Heart Failure Development","volume":"108","author":"Fujiu","year":"2013","journal-title":"Basic Res. Cardiol."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Saadat, S., Noureddini, M., Mahjoubin-Tehran, M., Nazemi, S., Shojaie, L., Aschner, M., Maleki, B., Abbasi-Kolli, M., Rajabi Moghadam, H., and Alani, B. (2021). Pivotal Role of TGF-\u03b2\/Smad Signaling in Cardiac Fibrosis: Non-Coding RNAs as Effectual Players. Front. Cardiovasc. Med., 7.","DOI":"10.3389\/fcvm.2020.588347"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1038\/s41467-017-00840-w","article-title":"Loss of \u03b2-Catenin in Resident Cardiac Fibroblasts Attenuates Fibrosis Induced by Pressure Overload in Mice","volume":"8","author":"Xiang","year":"2017","journal-title":"Nat. Commun."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.jacbts.2019.02.006","article-title":"Fibroblasts in the Infarcted, Remodeling, and Failing Heart","volume":"4","author":"Humeres","year":"2019","journal-title":"JACC Basic Transl. Sci."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Ga\u0142dyszy\u0144ska, M., Radwa\u0144ska, P., Szyma\u0144ski, J., and Drobnik, J. (2021). The Stiffness of Cardiac Fibroblast Substrates Exerts a Regulatory Influence on Collagen Metabolism via \u03b12\u03b21 Integrin, FAK and Src Kinases. Cells, 10.","DOI":"10.3390\/cells10123506"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"151288","DOI":"10.1016\/j.ejcb.2023.151288","article-title":"Mechanical Stress Regulates the Mechanotransduction and Metabolism of Cardiac Fibroblasts in Fibrotic Cardiac Diseases","volume":"102","author":"Tian","year":"2023","journal-title":"Eur. J. Cell Biol."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Peh, Z.H., Dihoum, A., Hutton, D., Arthur, J.S.C., Rena, G., Khan, F., Lang, C.C., and Mordi, I.R. (2023). Inflammation as a Therapeutic Target in Heart Failure with Preserved Ejection Fraction. Front. Cardiovasc. Med., 10.","DOI":"10.3389\/fcvm.2023.1125687"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"101194","DOI":"10.1016\/j.mam.2023.101194","article-title":"Cardiac Fibrosis in Heart Failure: Focus on Non-Invasive Diagnosis and Emerging Therapeutic Strategies","volume":"93","author":"Ravassa","year":"2023","journal-title":"Mol. Asp. Med."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Zhu, L., Wang, Y., Zhao, S., and Lu, M. (2022). Detection of Myocardial Fibrosis: Where We Stand. Front. Cardiovasc. Med., 9.","DOI":"10.3389\/fcvm.2022.926378"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Zaborska, B., Sikora-Fr\u0105c, M., Smar\u017c, K., Pilichowska-Paszkiet, E., Budaj, A., Sitkiewicz, D., and Sygitowicz, G. (2023). The Role of Galectin-3 in Heart Failure\u2014The Diagnostic, Prognostic and Therapeutic Potential\u2014Where Do We Stand?. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms241713111"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Rajah, M.R., Marais, E., Maarman, G.J., Doubell, E., Doubell, A.F., and Herbst, P.G. (2025). Utility of Serum Biomarkers of Myocardial Fibrosis in High-Gradient Severe Aortic Stenosis: An Explorative Cardiovascular Magnetic Resonance Imaging-Based Study. Diagnostics, 15.","DOI":"10.3390\/diagnostics15091143"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"165","DOI":"10.31083\/j.rcm2305165","article-title":"Cardiac Hypertrophy: From Pathophysiological Mechanisms to Heart Failure Development","volume":"23","author":"Caturano","year":"2022","journal-title":"Rev. Cardiovasc. Med."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Sun, J., Zhou, D., and Cheng, M. (2025). Potential Biomarker and Therapeutic Tools for Pathological Cardiac Hypertrophy and Heart Failure: Extracellular Vesicles. Int. J. Mol. Sci., 27.","DOI":"10.3390\/ijms27010095"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/s41569-018-0007-y","article-title":"Mechanisms of Physiological and Pathological Cardiac Hypertrophy","volume":"15","author":"Nakamura","year":"2018","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"\u017debrauskien\u0117, D., Sadauskien\u0117, E., Puronait\u0117, R., Masiulien\u0117, R., Vai\u0161nor\u0117, R., Brat\u010dikovien\u0117, N., Valevi\u010dien\u0117, N., Barysien\u0117, J., Jakaitien\u0117, A., and Preik\u0161aitien\u0117, E. (2025). Genotype-Phenotype Relationship in Hypertrophic Cardiomyopathy. Genes, 16.","DOI":"10.3390\/genes16091090"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.yjmcc.2022.07.007","article-title":"A Perinuclear Calcium Compartment Regulates Cardiac Myocyte Hypertrophy","volume":"172","author":"Turcotte","year":"2022","journal-title":"J. Mol. Cell. Cardiol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.tcm.2022.01.002","article-title":"MEF2 in Cardiac Hypertrophy in Response to Hypertension","volume":"33","author":"Cornwell","year":"2023","journal-title":"Trends Cardiovasc. Med."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s00395-013-0361-1","article-title":"Epigenetics: A New Mechanism of Regulation of Heart Failure?","volume":"108","author":"Papait","year":"2013","journal-title":"Basic Res. Cardiol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1186\/s13023-023-02896-y","article-title":"HDAC5 Inhibition Attenuates Ventricular Remodeling and Cardiac Dysfunction","volume":"18","author":"Zhu","year":"2023","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Han, Y., Nie, J., Wang, D.W., and Ni, L. (2022). Mechanism of Histone Deacetylases in Cardiac Hypertrophy and Its Therapeutic Inhibitors. Front. Cardiovasc. Med., 9.","DOI":"10.3389\/fcvm.2022.931475"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s12265-018-9797-x","article-title":"Noncoding RNAs in Cardiac Hypertrophy","volume":"11","author":"Li","year":"2018","journal-title":"J. Cardiovasc. Transl. Res."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1093\/cvr\/cvaf008","article-title":"Down-Regulation of Histone Deacetylase 2 Attenuates Ventricular Arrhythmias in a Mouse Model of Cardiac Hypertrophy Through Up-Regulation of Kv Channel-Interacting Protein 2 Expression","volume":"121","author":"Liu","year":"2025","journal-title":"Cardiovasc. Res."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3892\/ijmm.2025.5566","article-title":"Molecular Mechanisms and Intervention Approaches of Heart Failure","volume":"56","author":"Guo","year":"2025","journal-title":"Int. J. Mol. Med."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1038\/s41401-023-01068-9","article-title":"Regulated Cell Death Pathways in Cardiomyopathy","volume":"44","author":"Sheng","year":"2023","journal-title":"Acta Pharmacol. Sin."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s00395-025-01101-4","article-title":"Necrosis Like Cell Death Modes in Heart Failure: The Influence of Aetiology and the Effects of RIP3 Inhibition","volume":"120","author":"Kopkan","year":"2025","journal-title":"Basic Res. Cardiol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"38407","DOI":"10.31083\/RCM38407","article-title":"Programmed Cell Death in Heart Failure: Mechanisms, Impacts, and Therapeutic Prospects","volume":"26","author":"Wu","year":"2025","journal-title":"Rev. Cardiovasc. Med."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1161\/HYPERTENSIONAHA.119.14556","article-title":"Redox Regulation of Cardiac ASK1 (Apoptosis Signal Regulating Kinase 1) Controls p38 MAPK (Mitogen Activated Protein Kinase) and Orchestrates Cardiac Remodeling to Hypertension","volume":"76","author":"Meijles","year":"2020","journal-title":"Hypertension"},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Niu, Y., Wang, L., Zhang, Y., Zou, Y., and Zhou, C. (2025). Pyroptosis in Cardiovascular Diseases: Roles, Mechanisms, and Clinical Implications. Front. Cardiovasc. Med., 12.","DOI":"10.3389\/fcvm.2025.1629016"},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Fatima, S., Zhou, H., Chen, Y., and Liu, Q. (2024). Role of Ferroptosis in the Pathogenesis of Heart Disease. Front. Physiol., 15.","DOI":"10.3389\/fphys.2024.1450656"},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Wang, J., Li, Y., Li, L., Liang, H., Ye, H., Kang, P., Li, Z., Yu, Y., and Gao, Q. (2024). Effect of NLRP3 Gene Knockdown on Pyroptosis and Ferroptosis in Diabetic Cardiomyopathy Injury. BMC Cardiovasc. Disord., 24.","DOI":"10.1186\/s12872-024-04010-x"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"102932","DOI":"10.1016\/j.arr.2025.102932","article-title":"Ferroptosis and Pyroptosis: Mediating Mechanisms of the cGAS\/STING Pathway and Therapeutic Strategies in Heart Failure","volume":"113","author":"Zhang","year":"2026","journal-title":"Ageing Res. Rev."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ijcard.2020.04.015","article-title":"Inhibition of Apoptosis Signal Regulating Kinase 1 Ameliorates Left Ventricular Dysfunction by Reducing Hypertrophy and Fibrosis in a Rat Model of Cardiorenal Syndrome","volume":"310","author":"Savira","year":"2020","journal-title":"Int. J. Cardiol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/s41576-023-00611-y","article-title":"microRNAs in Action: Biogenesis, Function and Regulation","volume":"24","author":"Shang","year":"2023","journal-title":"Nat. Rev. Genet."},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"de Mello, A.S., Ferguson, B.S., Shebs Maurine, E.L., and Giotto, F.M. (2024). MicroRNA Biogenesis, Gene Regulation Mechanisms, and Availability in Foods. Non-Coding RNA, 10.","DOI":"10.3390\/ncrna10050052"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1080\/15476286.2023.2288741","article-title":"Recent Progress in miRNA Biogenesis and Decay","volume":"21","year":"2024","journal-title":"RNA Biol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.5114\/aoms\/169775","article-title":"Cardiac microRNAs: Diagnostic and Therapeutic Potential","volume":"19","author":"Badacz","year":"2023","journal-title":"Arch. Med. Sci."},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"D\u2019Amato, A., Prosperi, S., Severino, P., Myftari, V., Correale, M., Perrone Filardi, P., Badagliacca, R., Fedele, F., Vizza, C.D., and Palazzuoli, A. (2024). MicroRNA and Heart Failure: A Novel Promising Diagnostic and Therapeutic Tool. J. Clin. Med., 13.","DOI":"10.3390\/jcm13247560"},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Vu, B.Q., Huynh, P.A., Nguyen, N.N.Q., Vo, N.V.T., Le, L.G.H., Vu, V.H., Nguyen, T.C., Hoang, M., and Vu, D.M. (2025). Comprehensive Profiling Identifies Circulating microRNA Dysregulation in Vietnamese Patients with Heart Failure. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26189076"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1089\/hum.2024.113","article-title":"Advances in MicroRNA Therapeutics: From Preclinical to Clinical Studies","volume":"35","author":"Brillante","year":"2024","journal-title":"Hum. Gene Ther."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"O\u2019Brien, J., Hayder, H., Zayed, Y., and Peng, C. (2018). Overview of MicroRNA Biogenesis, Mechanisms of Actions, and Circulation. Front. Endocrinol., 9.","DOI":"10.3389\/fendo.2018.00402"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"4051","DOI":"10.1038\/sj.emboj.7600385","article-title":"MicroRNA Genes Are Transcribed by RNA Polymerase II","volume":"23","author":"Lee","year":"2004","journal-title":"EMBO J."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"E4961","DOI":"10.1073\/pnas.1618732114","article-title":"An Exportin 1-Dependent MicroRNA Biogenesis Pathway during Human Cell Quiescence","volume":"114","author":"Martinez","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.gpb.2017.09.004","article-title":"The Role of Exportin-5 in MicroRNA Biogenesis and Cancer","volume":"16","author":"Wu","year":"2018","journal-title":"Genom. Proteom. Bioinform."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/nrm3838","article-title":"Regulation of MicroRNA Biogenesis","volume":"15","author":"Ha","year":"2014","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1261\/rna.068692.118","article-title":"Post-Transcriptional Control of miRNA Biogenesis","volume":"25","author":"Michlewski","year":"2019","journal-title":"RNA"},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Yoshida, T., Asano, Y., and Ui-Tei, K. (2021). Modulation of MicroRNA Processing by Dicer via Its Associated dsRNA Binding Proteins. Non-Coding RNA, 7.","DOI":"10.3390\/ncrna7030057"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/s41580-018-0059-1","article-title":"Regulation of MicroRNA Biogenesis and Its Crosstalk with Other Cellular Pathways","volume":"20","author":"Treiber","year":"2019","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"4626","DOI":"10.1093\/nar\/gks026","article-title":"Biogenesis of Mammalian microRNAs by a Non-Canonical Processing Pathway","volume":"40","author":"Havens","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Nowak, I., and Sarshad, A.A. (2021). Argonaute Proteins Take Center Stage in Cancers. Cancers, 13.","DOI":"10.3390\/cancers13040788"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"11867","DOI":"10.1093\/nar\/gkx916","article-title":"Human Argonaute3 Has Slicer Activity","volume":"45","author":"Park","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"90","DOI":"10.3892\/ijmm.2025.5531","article-title":"Current Updates Regarding Biogenesis, Functions and Dysregulation of microRNAs in Cancer: Innovative Approaches for Detection Using CRISPR\/Cas13 Based Platforms (Review)","volume":"55","author":"Aloliqi","year":"2025","journal-title":"Int. J. Mol. Med."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.molcel.2018.07.020","article-title":"Argonaute\u2013miRNA Complexes Silence Target mRNAs in the Nucleus of Mammalian Stem Cells","volume":"71","author":"Sarshad","year":"2018","journal-title":"Mol. Cell"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"11097","DOI":"10.1093\/nar\/gkaa827","article-title":"ERH Facilitates microRNA Maturation through the Interaction with the N-Terminus of DGCR8","volume":"48","author":"Kwon","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"7913","DOI":"10.1038\/s41467-025-63015-y","article-title":"ERH Promotes Primary microRNA Processing beyond Cluster Assistance","volume":"16","author":"Jang","year":"2025","journal-title":"Nat. Commun."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1101\/gad.352815.125","article-title":"An Intrinsically Disordered Region of Drosha Selectively Promotes miRNA Biogenesis, Independent of Tissue-Specific Microprocessor Condensates","volume":"40","author":"Yang","year":"2026","journal-title":"Genes Dev."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"107971","DOI":"10.1016\/j.isci.2023.107971","article-title":"Essential Role of the Amino-Terminal Region of Drosha for the Microprocessor Function","volume":"26","author":"Prabhakar","year":"2023","journal-title":"iScience"},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Theotoki, E.I., Kakoulidis, P., Papavassiliou, K.A., Nikolakopoulos, K.-S., Vlachou, E.N., Basdra, E.K., Papavassiliou, A.G., Tsitsilonis, O.E., Voutsinas, G.E., and Velentzas, A.D. (2025). Non-Canonical Compartmentalization of DROSHA Protein at the Golgi Apparatus: miRNA Biogenesis-Independent Functionality in Human Cancer Cells of Diverse Tissue Origin. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26199319"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"6443","DOI":"10.1016\/j.csbj.2022.11.036","article-title":"Consequences of Genetic Variants in miRNA Genes","volume":"20","author":"Machowska","year":"2022","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"gkaf868","DOI":"10.1093\/nar\/gkaf868","article-title":"DDX6 Interacts with DDX3X to Repress Translation in microRNA-Mediated Silencing","volume":"53","author":"Lu","year":"2025","journal-title":"Nucleic Acids Res."},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"Wang, T., Tian, S., Tikhonova, E.B., Karamyshev, A.L., Wang, J.J., Zhang, F., and Wang, D. (2023). The Enrichment of miRNA-Targeted mRNAs in Translationally Less Active over More Active Polysomes. Biology, 12.","DOI":"10.3390\/biology12121536"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1111\/febs.16422","article-title":"The Intricate Balance between microRNA-Induced mRNA Decay and Translational Repression","volume":"290","author":"Naeli","year":"2023","journal-title":"FEBS J."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"e70948","DOI":"10.7554\/eLife.70948","article-title":"Inducible and Reversible Inhibition of miRNA-Mediated Gene Repression In Vivo","volume":"10","author":"King","year":"2021","journal-title":"eLife"},{"key":"ref_84","doi-asserted-by":"crossref","unstructured":"Sumaiya, K., Ponnusamy, T., Natarajaseenivasan, K., and Shanmughapriya, S. (2022). Cardiac Metabolism and MiRNA Interference. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24010050"},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Klimczak-Tomaniak, D., Haponiuk-Skwarli\u0144ska, J., Kuch, M., and P\u0105czek, L. (2022). Crosstalk between microRNA and Oxidative Stress in Heart Failure: A Systematic Review. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms232315013"},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Fumarulo, I., De Prisco, A., Salerno, E.N.M., Ravenna, S.E., Vaccarella, M., Garramone, B., Burzotta, F., and Aspromonte, N. (2025). New Frontiers of microRNA in Heart Failure: From Clinical Risk to Therapeutic Applications. J. Clin. Med., 14.","DOI":"10.3390\/jcm14186361"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1038\/nsmb.2149","article-title":"miRNA-Mediated Deadenylation Is Orchestrated by GW182 through Two Conserved Motifs That Interact with CCR4\u2013NOT","volume":"18","author":"Fabian","year":"2011","journal-title":"Nat. Struct. Mol. Biol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"102460","DOI":"10.1016\/j.sbi.2022.102460","article-title":"Regulation of the Multisubunit CCR4\u2013NOT Deadenylase in the Initiation of mRNA Degradation","volume":"77","author":"Raisch","year":"2022","journal-title":"Curr. Opin. Struct. Biol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"21","DOI":"10.14348\/molcells.2023.2157","article-title":"Determinants of Functional MicroRNA Targeting","volume":"46","author":"Hwang","year":"2023","journal-title":"Mol. Cells"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"eadq8587","DOI":"10.1126\/science.adq8587","article-title":"Specific tRNAs Promote mRNA Decay by Recruiting the CCR4\u2013NOT Complex to Translating Ribosomes","volume":"386","author":"Zhu","year":"2024","journal-title":"Science"},{"key":"ref_91","doi-asserted-by":"crossref","unstructured":"Zhang, W., Wang, L., Demna, M.Y., Xiong, J., Luo, M., Wang, Y., and Wang, F. (2025). Regulatory Mechanisms of miRNA Turnover: Insights into ZSWIM8-Mediated Target-Directed MicroRNA Degradation. Biomedicines, 13.","DOI":"10.3390\/biomedicines13092194"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1002\/ehf2.14153","article-title":"MicroRNAs: Diagnostic, Prognostic and Therapeutic Role in Heart Failure\u2014A Review","volume":"10","author":"Gargiulo","year":"2023","journal-title":"ESC Heart Fail."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1007\/s11886-023-01895-6","article-title":"The Effects of MicroRNAs in the Development of Heart Failure","volume":"25","author":"Guo","year":"2023","journal-title":"Curr. Cardiol. Rep."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1515\/mr-2021-0001","article-title":"MicroRNAs in Cardiovascular Diseases","volume":"2","author":"Li","year":"2022","journal-title":"Med. Rev."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.yjmcc.2016.03.015","article-title":"Cardiac-Specific miRNA in Cardiogenesis, Heart Function, and Cardiac Pathology (with Focus on Myocardial Infarction)","volume":"94","author":"Chistiakov","year":"2016","journal-title":"J. Mol. Cell. Cardiol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1101\/gad.1753508","article-title":"Right into the Heart of microRNA-133a","volume":"22","author":"Meder","year":"2008","journal-title":"Genes Dev."},{"key":"ref_97","first-page":"101310","article-title":"Conservation of miR Combo-Based Direct Cardiac Reprogramming","volume":"31","author":"Baksh","year":"2022","journal-title":"Biochem. Biophys. Rep."},{"key":"ref_98","doi-asserted-by":"crossref","unstructured":"Liu, Y., Afzal, J., Vakrou, S., Greenland, G.V., Talbot, C.C., Hebl, V.B., Guan, Y., Karmali, R., Tardiff, J.C., and Leinwand, L.A. (2019). Differences in microRNA-29 and Pro-Fibrotic Gene Expression in Mouse and Human Hypertrophic Cardiomyopathy. Front. Cardiovasc. Med., 6.","DOI":"10.3389\/fcvm.2019.00170"},{"key":"ref_99","doi-asserted-by":"crossref","unstructured":"Zhao, Y., Du, D., Chen, S., Chen, Z., and Zhao, J. (2022). New Insights into the Functions of MicroRNAs in Cardiac Fibrosis: From Mechanisms to Therapeutic Strategies. Genes, 13.","DOI":"10.3390\/genes13081390"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.tcb.2015.07.011","article-title":"The Functions of MicroRNAs: mRNA Decay and Translational Repression","volume":"25","author":"Iwakawa","year":"2015","journal-title":"Trends Cell Biol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.1093\/eurheartj\/ehx165","article-title":"Non-Coding RNAs in Cardiovascular Diseases: Diagnostic and Therapeutic Perspectives","volume":"39","author":"Poller","year":"2018","journal-title":"Eur. Heart J."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1093\/ehjcvp\/pvae027","article-title":"Non-Coding RNA Therapeutics in the Treatment of Heart Failure","volume":"10","author":"Paterek","year":"2024","journal-title":"Eur. Heart J. Cardiovasc. Pharmacother."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1002\/ejhf.495","article-title":"MicroRNAs in Heart Failure: From Biomarker to Target for Therapy","volume":"18","author":"Vegter","year":"2016","journal-title":"Eur. J. Heart Fail."},{"key":"ref_104","doi-asserted-by":"crossref","unstructured":"Psarras, S., Beis, D., Nikouli, S., Tsikitis, M., and Capetanaki, Y. (2019). Three in a Box: Understanding Cardiomyocyte, Fibroblast, and Innate Immune Cell Interactions to Orchestrate Cardiac Repair Processes. Front. Cardiovasc. Med., 6.","DOI":"10.3389\/fcvm.2019.00032"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"13945","DOI":"10.1038\/s41598-020-70848-8","article-title":"Sex-Specific MicroRNAs in Women with Diabetes and Left Ventricular Diastolic Dysfunction or HFpEF Associate with Microvascular Injury","volume":"10","author":"Florijn","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_106","doi-asserted-by":"crossref","unstructured":"Peterlin, A., Po\u010divav\u0161ek, K., Petrovi\u010d, D., and Peterlin, B. (2020). The Role of microRNAs in Heart Failure: A Systematic Review. Front. Cardiovasc. Med., 7.","DOI":"10.3389\/fcvm.2020.00161"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"42","DOI":"10.14797\/mdcvj.1381","article-title":"Role of Imaging and Biomarkers in Identifying, Monitoring, and Promoting Myocardial Recovery","volume":"20","author":"Meekers","year":"2024","journal-title":"Methodist Debakey Cardiovasc. J."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/ehf2.14857","article-title":"2024 Update in Heart Failure","volume":"12","author":"Beghini","year":"2024","journal-title":"ESC Heart Fail."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1016\/j.jacc.2007.09.021","article-title":"Natriuretic Peptides","volume":"50","author":"Daniels","year":"2007","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/s41467-020-14349-2","article-title":"Preclinical Development of a miR-132 Inhibitor for Heart Failure Treatment","volume":"11","author":"Foinquinos","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1038\/ncomms2090","article-title":"The miRNA-212\/132 Family Regulates Both Cardiac Hypertrophy and Cardiomyocyte Autophagy","volume":"3","author":"Ucar","year":"2012","journal-title":"Nat. Commun."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1093\/eurheartj\/ehaa791","article-title":"CDR132L Improves Systolic and Diastolic Function in a Large Animal Model of Chronic Heart Failure","volume":"42","author":"Batkai","year":"2021","journal-title":"Eur. Heart J."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1093\/eurheartj\/ehaa898","article-title":"Novel Antisense Therapy Targeting MicroRNA-132 in Patients with Heart Failure: Results of a First-in-Human Phase 1b Randomized, Double-Blind, Placebo-Controlled Study","volume":"42","author":"Hauke","year":"2021","journal-title":"Eur. Heart J."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1002\/ejhf.3139","article-title":"Efficacy and Safety of CDR132L in Patients with Reduced Left Ventricular Ejection Fraction after Myocardial Infarction: Rationale and Design of the HF-REVERT Trial","volume":"26","author":"Bauersachs","year":"2024","journal-title":"Eur. J. Heart Fail."},{"key":"ref_115","doi-asserted-by":"crossref","unstructured":"Surina, S., Fontanella, R.A., Scisciola, L., Marfella, R., Paolisso, G., and Barbieri, M. (2021). miR-21 in Human Cardiomyopathies. Front. Cardiovasc. Med., 8.","DOI":"10.3389\/fcvm.2021.767064"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s42452-025-06888-4","article-title":"miR-21 in Cardiovascular Disease: New Insights and Emerging Therapeutic Potential","volume":"7","author":"Mollajan","year":"2025","journal-title":"Discov. Appl. Sci."},{"key":"ref_117","doi-asserted-by":"crossref","unstructured":"Wang, L., Guo, A., Liang, S., Yu, L., Shen, B., and Huang, Z. (2025). The Association of Serum hsa-miR-21-5p Expression with the Severity and Prognosis of Heart Failure with Reduced Ejection Fraction. BMC Cardiovasc. Disord., 25.","DOI":"10.1186\/s12872-024-04465-y"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.cardfail.2025.01.020","article-title":"Differences between Ischemic and Nonischemic Cardiomyopathy in Heart Failure Related Cardiogenic Shock","volume":"31","author":"Feinman","year":"2025","journal-title":"J. Card. Fail."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"150336","DOI":"10.1016\/j.bbrc.2024.150336","article-title":"Small Extracellular Vesicles Associated miRNA in Myocardial Fibrosis","volume":"727","author":"Long","year":"2024","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_120","doi-asserted-by":"crossref","unstructured":"Momin, M.Y., Gaddam, R.R., Kravitz, M., Gupta, A., and Vikram, A. (2021). The Challenges and Opportunities in the Development of MicroRNA Therapeutics: A Multidisciplinary Viewpoint. Cells, 10.","DOI":"10.3390\/cells10113097"},{"key":"ref_121","doi-asserted-by":"crossref","unstructured":"Hueso, M., Mall\u00e9n, A., Su\u00f1\u00e9-Pou, M., Aran, J.M., Su\u00f1\u00e9-Negre, J.M., and Navarro, E. (2021). ncRNAs in Therapeutics: Challenges and Limitations in Nucleic Acid-Based Drug Delivery. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms222111596"},{"key":"ref_122","doi-asserted-by":"crossref","unstructured":"Moraes, F.C., Pichon, C., Letourneur, D., and Chaubet, F. (2021). miRNA Delivery by Nanosystems: State of the Art and Perspectives. Pharmaceutics, 13.","DOI":"10.3390\/pharmaceutics13111901"},{"key":"ref_123","doi-asserted-by":"crossref","unstructured":"Jalink, E.A., Schonk, A.W., Boon, R.A., and Juni, R.P. (2024). Non-Coding RNAs in the Pathophysiology of Heart Failure with Preserved Ejection Fraction. Front. Cardiovasc. Med., 10.","DOI":"10.3389\/fcvm.2023.1300375"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1093\/eurheartj\/ehy234","article-title":"Circulating Non-Coding RNAs in Biomarker-Guided Cardiovascular Therapy: A Novel Tool for Personalized Medicine?","volume":"40","author":"Vea","year":"2019","journal-title":"Eur. Heart J."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.1002\/ehf2.15324","article-title":"Multi-MicroRNA Diagnostic Panel for Heart Failure with Preserved Ejection Fraction in Preclinical and Clinical Settings","volume":"12","author":"Parvan","year":"2025","journal-title":"ESC Heart Fail."},{"key":"ref_126","doi-asserted-by":"crossref","unstructured":"Parvan, R., Becker, V., Hosseinpour, M., Moradi, Y., Louch, W.E., Cataliotti, A., Devaux, Y., Frisk, M., and Silva, G.J.J. (2025). Prognostic and Predictive MicroRNA Panels for Heart Failure Patients with Reduced or Preserved Ejection Fraction: A Meta-Analysis of Kaplan\u2013Meier-Based Individual Patient Data. BMC Med., 23.","DOI":"10.1186\/s12916-025-04238-0"},{"key":"ref_127","doi-asserted-by":"crossref","unstructured":"Asta, L., Pisano, C., Sbrigata, A., Raffa, G.M., Scola, L., and Balistreri, C.R. (2025). Biomarkers in Heart Failure: A Review and a Wish. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26168046"},{"key":"ref_128","doi-asserted-by":"crossref","unstructured":"Rasooly, D., Pereira, A.C., and Joseph, J. (2025). Drug Discovery and Development for Heart Failure Using Multi-Omics Approaches. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26062703"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"e2200289","DOI":"10.1002\/pmic.202200289","article-title":"Multi-Omic Analyses and Network Biology in Cardiovascular Disease","volume":"23","author":"Reitz","year":"2023","journal-title":"Proteomics"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"e27744","DOI":"10.1097\/MD.0000000000027744","article-title":"Prognostic Value of microRNAs in Heart Failure: A Meta-Analysis","volume":"100","author":"Yang","year":"2021","journal-title":"Medicine"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"17615","DOI":"10.1073\/pnas.1206432109","article-title":"Therapeutic Inhibition of the miR-34 Family Attenuates Pathological Cardiac Remodeling and Improves Heart Function","volume":"109","author":"Bernardo","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_132","doi-asserted-by":"crossref","unstructured":"Li, N., Zhou, H., and Tang, Q. (2018). miR-133: A Suppressor of Cardiac Remodeling?. Front. Pharmacol., 9.","DOI":"10.3389\/fphar.2018.00903"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.ymthe.2018.11.011","article-title":"Therapeutic Delivery of miR-148a Suppresses Ventricular Dilation in Heart Failure","volume":"27","author":"Raso","year":"2019","journal-title":"Mol. Ther."},{"key":"ref_134","doi-asserted-by":"crossref","unstructured":"Dai, B., Wang, F., Nie, X., Du, H., Zhao, Y., Yin, Z., Li, H., Fan, J., Wen, Z., and Wang, D.W. (2020). The Cell Type-Specific Functions of miR-21 in Cardiovascular Diseases. Front. Genet., 11.","DOI":"10.3389\/fgene.2020.563166"},{"key":"ref_135","doi-asserted-by":"crossref","unstructured":"Wehbe, N., Nasser, S.A., Pintus, G., Badran, A., Eid, A.H., and Baydoun, E. (2019). MicroRNAs in Cardiac Hypertrophy. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20194714"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1124\/jpet.121.001152","article-title":"The Role of microRNA in the Development, Diagnosis, and Treatment of Cardiovascular Disease: Recent Developments","volume":"384","author":"Wronska","year":"2023","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"4808","DOI":"10.1038\/s41467-021-25211-4","article-title":"A microRNA Program Regulates the Balance between Cardiomyocyte Hyperplasia and Hypertrophy and Stimulates Cardiac Regeneration","volume":"12","author":"Raso","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_138","doi-asserted-by":"crossref","unstructured":"Chiti, E., Di Paolo, M., Turillazzi, E., and Rocchi, A. (2021). MicroRNAs in Hypertrophic, Arrhythmogenic and Dilated Cardiomyopathy. Diagnostics, 11.","DOI":"10.3390\/diagnostics11091720"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1093\/cvr\/cvab248","article-title":"MicroRNA-27b-3p Down-Regulates FGF1 and Aggravates Pathological Cardiac Remodelling","volume":"118","author":"Li","year":"2022","journal-title":"Cardiovasc. Res."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1172\/JCI70577","article-title":"Cardiac Fibroblast-Derived microRNA Passenger Strand-Enriched Exosomes Mediate Cardiomyocyte Hypertrophy","volume":"124","author":"Bang","year":"2014","journal-title":"J. Clin. Invest."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"17539447241253134","DOI":"10.1177\/17539447241253134","article-title":"Inhibitory Effect of microRNA-21 on Pathways and Mechanisms Involved in Cardiac Fibrosis Development","volume":"18","author":"Khalaji","year":"2024","journal-title":"Ther. Adv. Cardiovasc. Dis."},{"key":"ref_142","doi-asserted-by":"crossref","unstructured":"Xue, R., Tan, W., Wu, Y., Dong, B., Xie, Z., Huang, P., He, J., Dong, Y., and Liu, C. (2020). Role of Exosomal miRNAs in Heart Failure. Front. Cardiovasc. Med., 7.","DOI":"10.3389\/fcvm.2020.592412"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"26","DOI":"10.53941\/ijddp.0201003","article-title":"Is miR-21 a Therapeutic Target in Cardiovascular Disease?","volume":"2","author":"Holland","year":"2023","journal-title":"Int. J. Drug Discov. Pharm."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1016\/j.jacc.2020.02.041","article-title":"AntimiR-21 Prevents Myocardial Dysfunction in a Pig Model of Ischemia\/Reperfusion Injury","volume":"75","author":"Hinkel","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_145","doi-asserted-by":"crossref","unstructured":"Alonso-Villa, E., Bonet, F., Hern\u00e1ndez-Torres, F., Campuzano, \u00d3., Sarquella-Brugada, G., Quezada-Feijoo, M., Ramos, M., Mangas, A., and Toro, R. (2022). The Role of MicroRNAs in Dilated Cardiomyopathy: New Insights for an Old Entity. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms232113573"},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/nm1582","article-title":"MicroRNA-133 Controls Cardiac Hypertrophy","volume":"13","author":"Catalucci","year":"2007","journal-title":"Nat. Med."},{"key":"ref_147","doi-asserted-by":"crossref","unstructured":"Kambis, T.N., Shahshahan, H.R., Kar, S., Yadav, S.K., and Mishra, P.K. (2019). Transgenic Expression of miR-133a in the Diabetic Akita Heart Prevents Cardiac Remodeling and Cardiomyopathy. Front. Cardiovasc. Med., 6.","DOI":"10.3389\/fcvm.2019.00045"},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/s41420-021-00552-7","article-title":"m6A Modification Promotes miR-133a Repression during Cardiac Development and Hypertrophy via IGF2BP2","volume":"7","author":"Qian","year":"2021","journal-title":"Cell Death Discov."},{"key":"ref_149","first-page":"72","article-title":"Tissue Engineering by Decellularization and 3D Bioprinting","volume":"8","author":"Chen","year":"2017","journal-title":"Stem Cell Res. Ther."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.ymthe.2024.01.037","article-title":"m6A Epitranscriptomic and Epigenetic Crosstalk in Cardiac Fibrosis","volume":"32","author":"Liu","year":"2024","journal-title":"Mol. Ther."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.stemcr.2014.10.010","article-title":"miR-133a Enhances the Protective Capacity of Cardiac Progenitor Cells after Myocardial Infarction","volume":"3","author":"Izarra","year":"2014","journal-title":"Stem Cell Rep."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"e000078","DOI":"10.1161\/JAHA.113.000078","article-title":"Therapeutic Cardiac-Targeted Delivery of miR-1 Reverses Pressure Overload-Induced Cardiac Hypertrophy and Attenuates Pathological Remodeling","volume":"2","author":"Karakikes","year":"2013","journal-title":"J. Am. Heart Assoc."},{"key":"ref_153","first-page":"43","article-title":"MicroRNAs: Novel Regulators of the Heart","volume":"2","author":"Xiao","year":"2010","journal-title":"J. Thorac. Dis."},{"key":"ref_154","doi-asserted-by":"crossref","unstructured":"S\u00e1nchez-Aguilera, P., L\u00f3pez-Crisosto, C., Norambuena-Soto, I., Penannen, C., Zhu, J., Bomer, N., Hoes, M.F., Van Der Meer, P., Chiong, M., and Westenbrink, B.D. (2023). IGF-1 Boosts Mitochondrial Function by a Ca2+ Uptake-Dependent Mechanism in Cultured Human and Rat Cardiomyocytes. Front. Physiol., 14.","DOI":"10.3389\/fphys.2023.1106662"},{"key":"ref_155","first-page":"133","article-title":"The Changes of Heart miR-1 and miR-133 Expressions Following Physiological Hypertrophy Due to Endurance Training","volume":"22","author":"Fathi","year":"2020","journal-title":"Cell J."},{"key":"ref_156","doi-asserted-by":"crossref","unstructured":"Tang, L.-Q., Wang, W., Tang, Q.-F., and Wang, L.-L. (2024). The Molecular Mechanism of miR-26a-5p Regulates Autophagy and Activates NLRP3 Inflammasome to Mediate Cardiomyocyte Hypertrophy. BMC Cardiovasc. Disord., 24.","DOI":"10.1186\/s12872-023-03695-w"},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1002\/cbin.11685","article-title":"miR-26a-5p Alleviates Cardiac Hypertrophy and Dysfunction via Targeting ADAM17","volume":"45","author":"Shi","year":"2021","journal-title":"Cell Biol. Int."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1093\/cvr\/cvad184","article-title":"miR-222 Inhibits Pathological Cardiac Hypertrophy and Heart Failure","volume":"120","author":"Liu","year":"2024","journal-title":"Cardiovasc. Res."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"e18546","DOI":"10.1111\/jcmm.18546","article-title":"The Role of miR-128 and MDFI in Cardiac Hypertrophy and Heart Failure: Mechanistic Insights","volume":"28","author":"Sun","year":"2024","journal-title":"J. Cell. Mol. Med."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1161\/HYPERTENSIONAHA.117.10094","article-title":"MicroRNA-221\/222 Family Counteracts Myocardial Fibrosis in Pressure Overload-Induced Heart Failure","volume":"71","author":"Verjans","year":"2018","journal-title":"Hypertension"},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s11658-022-00349-1","article-title":"METTL3 Mediates Ang-II-Induced Cardiac Hypertrophy through Accelerating pri-miR-221\/222 Maturation in an m6A-Dependent Manner","volume":"27","author":"Zhang","year":"2022","journal-title":"Cell. Mol. Biol. Lett."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"18255","DOI":"10.1073\/pnas.0608791103","article-title":"A Signature Pattern of Stress-Responsive microRNAs That Can Evoke Cardiac Hypertrophy and Heart Failure","volume":"103","author":"Sutherland","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1152\/physiolgenomics.00141.2011","article-title":"The miR-29 Family: Genomics, Cell Biology, and Relevance to Renal and Cardiovascular Injury","volume":"44","author":"Kriegel","year":"2012","journal-title":"Physiol. Genom."},{"key":"ref_164","doi-asserted-by":"crossref","unstructured":"Caravia, X.M., Fanjul, V., Oliver, E., Roiz-Valle, D., Mor\u00e1n-\u00c1lvarez, A., Desd\u00edn-Mic\u00f3, G., Mittelbrunn, M., Cabo, R., Vega, J.A., and Rodr\u00edguez, F. (2018). The microRNA-29\/PGC1\u03b1 Regulatory Axis Is Critical for Metabolic Control of Cardiac Function. PLoS Biol., 16.","DOI":"10.1371\/journal.pbio.2006247"},{"key":"ref_165","doi-asserted-by":"crossref","unstructured":"Li, J., Donath, S., Li, Y., Qin, D., Prabhakar, B.S., and Li, P. (2010). miR-30 Regulates Mitochondrial Fission through Targeting p53 and the Dynamin-Related Protein-1 Pathway. PLoS Genet., 6.","DOI":"10.1371\/annotation\/4050116d-8daa-4b5a-99e9-34cdd13f6a26"},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/hep.23922","article-title":"Micro-RNA Profiling Reveals a Role for miR-29 in Human and Murine Liver Fibrosis","volume":"53","author":"Roderburg","year":"2011","journal-title":"Hepatology"},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1038\/nature07511","article-title":"MicroRNA-21 Contributes to Myocardial Disease by Stimulating MAP Kinase Signalling in Fibroblasts","volume":"456","author":"Thum","year":"2008","journal-title":"Nature"},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/nature11919","article-title":"MicroRNA-34a Regulates Cardiac Ageing and Function","volume":"495","author":"Boon","year":"2013","journal-title":"Nature"},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.4155\/fmc.15.107","article-title":"miRNA Therapeutics: A New Class of Drugs with Potential Therapeutic Applications in the Heart","volume":"7","author":"Bernardo","year":"2015","journal-title":"Future Med. Chem."},{"key":"ref_170","doi-asserted-by":"crossref","unstructured":"Hua, C.C., Liu, X.M., Liang, L.R., Wang, L.F., and Zhong, J.C. (2022). Targeting the microRNA-34a as a Novel Therapeutic Strategy for Cardiovascular Diseases. Front. Cardiovasc. Med., 8.","DOI":"10.3389\/fcvm.2021.784044"},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"13027","DOI":"10.1073\/pnas.0805038105","article-title":"Dysregulation of microRNAs after Myocardial Infarction Reveals a Role of miR-29 in Cardiac Fibrosis","volume":"105","author":"Sutherland","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_172","doi-asserted-by":"crossref","unstructured":"Lozano-Velasco, E., In\u00e1cio, J.M., Sousa, I., Guimar\u00e3es, A.R., Franco, D., Moura, G., and Belo, J.A. (2024). miRNAs in Heart Development and Disease. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25031673"},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1161\/CIRCRESAHA.111.247916","article-title":"Developing microRNA Therapeutics","volume":"110","author":"Purcell","year":"2012","journal-title":"Circ. Res."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/nature09267","article-title":"Mammalian microRNAs Predominantly Act to Decrease Target mRNA Levels","volume":"466","author":"Guo","year":"2010","journal-title":"Nature"},{"key":"ref_175","doi-asserted-by":"crossref","unstructured":"Mekala, N., Kurdys, J., Vicenzi, A.P., Weiler, L.R., Avramut, C., Vazquez, E.J., Ragina, N., and Rosca, M.G. (2021). miR-208a Regulates Mitochondrial Biogenesis in Metabolically Challenged Cardiomyocytes. Cells, 10.","DOI":"10.3390\/cells10113152"},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1038\/s42003-024-07050-3","article-title":"miR-21-3p Inhibitor Exerts Myocardial Protective Effects by Altering Macrophage Polarization State and Reducing Excessive Mitophagy","volume":"7","author":"Huang","year":"2024","journal-title":"Commun. Biol."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"112082","DOI":"10.1016\/j.mad.2025.112082","article-title":"Targeting Mitophagy in the Heart: Exploring the Therapeutic Potential of MicroRNAs","volume":"226","author":"Javadifar","year":"2025","journal-title":"Mech. Ageing Dev."},{"key":"ref_178","doi-asserted-by":"crossref","unstructured":"Shen, N.N., Qian, H., and Zhu, Y.F. (2025). The Expression Profiles and Roles of microRNAs in Cardiac Glucose Metabolism. Front. Endocrinol., 16.","DOI":"10.3389\/fendo.2025.1565385"},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.yjmcc.2024.11.004","article-title":"Inhibition of miR-92a Normalizes Vascular Gene Expression and Prevents Diastolic Dysfunction in Heart Failure with Preserved Ejection Fraction","volume":"198","author":"Kattih","year":"2025","journal-title":"J. Mol. Cell. Cardiol."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1172\/JCI33099","article-title":"MicroRNAs: Powerful New Regulators of Heart Disease and Provocative Therapeutic Targets","volume":"117","author":"Olson","year":"2007","journal-title":"J. Clin. Invest."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s10557-011-6289-5","article-title":"Role of microRNAs in Cardiac Remodeling and Heart Failure","volume":"25","author":"Topkara","year":"2011","journal-title":"Cardiovasc. Drugs Ther."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/s41420-025-02649-9","article-title":"Harnessing miRNA Therapeutics: A Novel Approach to Combat Heart and Brain Infarctions in Atherosclerosis","volume":"11","author":"Wang","year":"2025","journal-title":"Cell Death Discov."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1002\/biof.1979","article-title":"miR-34a\/SIRT1\/HIF-1\u03b1 Axis Is Involved in Cardiac Angiogenesis of Type 2 Diabetic Rats: The Protective Effect of Sodium Butyrate Combined with Treadmill Exercise","volume":"49","author":"Sarlak","year":"2023","journal-title":"Biofactors"},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"e029427","DOI":"10.1161\/JAHA.123.029427","article-title":"MicroRNA-34a-Dependent Attenuation of Angiogenesis in Right Ventricular Failure","volume":"13","author":"Reddy","year":"2024","journal-title":"J. Am. Heart Assoc."},{"key":"ref_185","doi-asserted-by":"crossref","unstructured":"Li, X., and Bi, X. (2023). Integrated Control of Fatty Acid Metabolism in Heart Failure. Metabolites, 13.","DOI":"10.3390\/metabo13050615"},{"key":"ref_186","doi-asserted-by":"crossref","unstructured":"Zhao, M., Qi, Q., Liu, S., Huang, R., Shen, J., Zhu, Y., Chai, J., Zheng, H., Wu, H., and Liu, H. (2022). MicroRNA-34a: A Novel Therapeutic Target in Fibrosis. Front. Physiol., 13.","DOI":"10.3389\/fphys.2022.895242"},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"149","DOI":"10.4149\/gpb_2022061","article-title":"Hypoxic Cardiomyocyte-Derived Exosomes Regulate Cardiac Fibroblast Activation, Apoptosis, Migration, and Ferroptosis through miR-208a\/b","volume":"42","author":"Guo","year":"2023","journal-title":"Gen. Physiol. Biophys."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"114984","DOI":"10.1016\/j.physbeh.2025.114984","article-title":"Genetic Deletion of microRNA-34 Unmasks Cardiac Vulnerability to Psychosocial Stress in Male Mice","volume":"299","author":"Ielpo","year":"2025","journal-title":"Physiol. Behav."},{"key":"ref_189","doi-asserted-by":"crossref","unstructured":"Huang, X.H., Li, J.L., Li, X.Y., Wang, S.X., Jiao, Z.H., Li, S.Q., Liu, J., and Ding, J. (2021). miR-208a in Cardiac Hypertrophy and Remodeling. Front. Cardiovasc. Med., 8.","DOI":"10.3389\/fcvm.2021.773314"},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"267","DOI":"10.22270\/jddt.v15i8.7336","article-title":"Biogenesis and Implication of miRNAs in the Development of Diseases and Their Theranostic Inhibitions","volume":"15","author":"Mandal","year":"2025","journal-title":"J. Drug Deliv. Ther."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1515\/cclm-2016-0576","article-title":"microRNAs in Cardiovascular Disease\u2014Clinical Application","volume":"55","author":"Schulte","year":"2017","journal-title":"Clin. Chem. Lab. Med."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/jcmm.12218","article-title":"Cardiac miR-133a Overexpression Prevents Early Cardiac Fibrosis in Diabetes","volume":"18","author":"Chen","year":"2014","journal-title":"J. Cell. Mol. Med."},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"3816","DOI":"10.1111\/jcmm.13654","article-title":"miR-21 Promotes Cardiac Fibroblast-to-Myofibroblast Transformation and Myocardial Fibrosis by Targeting Jagged1","volume":"22","author":"Zhou","year":"2018","journal-title":"J. Cell. Mol. Med."},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"105941","DOI":"10.1016\/j.phrs.2021.105941","article-title":"MicroRNA Targets and Biomarker Validation for Diabetes-Associated Cardiac Fibrosis","volume":"174","author":"Jin","year":"2021","journal-title":"Pharmacol. Res."},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1038\/mt.2014.25","article-title":"miR-29b as a Therapeutic Agent for Angiotensin II-Induced Cardiac Fibrosis by Targeting TGF-\u03b2\/Smad3 Signaling","volume":"22","author":"Zhang","year":"2014","journal-title":"Mol. Ther."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"506","DOI":"10.3892\/etm.2022.11433","article-title":"MicroRNA-146a Attenuates Isoproterenol-Induced Cardiac Fibrosis by Inhibiting FGF2","volume":"24","author":"Zhang","year":"2022","journal-title":"Exp. Ther. Med."},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s10557-011-6291-y","article-title":"MicroRNA Involvement in Immune Activation during Heart Failure","volume":"25","author":"Heymans","year":"2011","journal-title":"Cardiovasc. Drugs Ther."},{"key":"ref_198","doi-asserted-by":"crossref","unstructured":"Wu, C., Liu, B., Wang, R., and Li, G. (2022). Corrigendum: The Regulation Mechanisms and Clinical Application of MicroRNAs in Myocardial Infarction: A Review of the Recent 5 Years. Front. Cardiovasc. Med., 9.","DOI":"10.3389\/fcvm.2022.900621"},{"key":"ref_199","first-page":"1355","article-title":"MicroRNA-34a Regulates Cardiac Fibrosis after Myocardial Infarction by Targeting Smad4","volume":"18","author":"Huang","year":"2014","journal-title":"Expert Opin. Ther. Targets"},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"e18413","DOI":"10.1111\/jcmm.18413","article-title":"miR-31-5p Suppresses Myocardial Hypertrophy by Targeting Nfatc2ip","volume":"28","author":"Zhao","year":"2024","journal-title":"J. Cell. Mol. Med."},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1128\/MCB.01222-08","article-title":"MicroRNA-1 Negatively Regulates Expression of the Hypertrophy-Associated Calmodulin and Mef2a Genes","volume":"29","author":"Ikeda","year":"2009","journal-title":"Mol. Cell. Biol."},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"12103","DOI":"10.1073\/pnas.0811371106","article-title":"miR-23a Functions Downstream of NFATc3 to Regulate Cardiac Hypertrophy","volume":"106","author":"Lin","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1111\/jcmm.13928","article-title":"Systematic Identification and Analysis of Dysregulated miRNA and Transcription Factor Feed-Forward Loops in Hypertrophic Cardiomyopathy","volume":"23","author":"Shi","year":"2019","journal-title":"J. Cell. Mol. Med."},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"100818","DOI":"10.1016\/j.bj.2024.100818","article-title":"miR-424\/322 Attenuates Cardiac Remodeling by Modulating the Nuclear Factor-Activated T-Cell 3\/Furin Pathway","volume":"48","author":"Tsai","year":"2025","journal-title":"Biomed. J."},{"key":"ref_205","doi-asserted-by":"crossref","unstructured":"Wen, M., Zhang, X., Tong, L., Chen, Y., Li, Z., Wang, Y., Liu, C., Zhang, J., Ge, L., and Sun, J. (2025). The lncRNA Jpx Participates in Testosterone-Induced H9c2 Cell Hypertrophy by Targeting the miR-145-5p\/Nfatc3 Axis. Front. Cell Dev. Biol., 13.","DOI":"10.3389\/fcell.2025.1620369"},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"4037","DOI":"10.1113\/JP273129","article-title":"Non-Coding RNAs in Cardiac Hypertrophy","volume":"595","author":"Ottaviani","year":"2017","journal-title":"J. Physiol."},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1093\/cvr\/cvs001","article-title":"GATA4 Expression Is Primarily Regulated via a miR-26b-Dependent Post-Transcriptional Mechanism during Cardiac Hypertrophy","volume":"93","author":"Han","year":"2012","journal-title":"Cardiovasc. Res."},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1093\/cvr\/cvz215","article-title":"Circular RNA circRNA_000203 Aggravates Cardiac Hypertrophy via Suppressing miR-26b-5p and miR-140-3p Binding to Gata4","volume":"116","author":"Li","year":"2020","journal-title":"Cardiovasc. Res."},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/s00018-023-04699-7","article-title":"Circ-sh3rf3\/GATA-4\/miR-29a Regulatory Axis in Fibroblast-Myofibroblast Differentiation and Myocardial Fibrosis","volume":"80","author":"Ma","year":"2023","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_210","doi-asserted-by":"crossref","unstructured":"Alali, R., Almansori, M., Vatte, C., Akhtar, M.S., Abduljabbar, S.S., Al-Matroud, H., Alnuwaysir, M.J., Radhi, H.A., Keating, B., and Habara, A. (2025). Circular RNAs in Cardiovascular Disease: Mechanisms, Biomarkers, and Therapeutic Frontiers. Biomolecules, 15.","DOI":"10.3390\/biom15101455"},{"key":"ref_211","doi-asserted-by":"crossref","unstructured":"Mad\u00e8, A., Bibi, A., Garcia-Manteiga, J.M., Tascini, A.S., Piella, S.N., Tikhomirov, R., Voellenkle, C., Gaetano, C., Leszek, P., and Castelvecchio, S. (2023). circRNA-miRNA-mRNA Deregulated Network in Ischemic Heart Failure Patients. Cells, 12.","DOI":"10.3390\/cells12212578"},{"key":"ref_212","doi-asserted-by":"crossref","unstructured":"Yang, T., Long, T., Du, T., Chen, Y., Dong, Y., and Huang, Z.P. (2021). Circle the Cardiac Remodeling with circRNAs. Front. Cardiovasc. Med., 8.","DOI":"10.3389\/fcvm.2021.702586"},{"key":"ref_213","doi-asserted-by":"crossref","unstructured":"Sygitowicz, G., and Sitkiewicz, D. (2022). Involvement of circRNAs in the Development of Heart Failure. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms232214129"},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"e9796","DOI":"10.7717\/peerj.9796","article-title":"CircHIPK3 Regulates Cardiac Fibroblast Proliferation, Migration and Phenotypic Switching through the miR-152-3p\/TGF-\u03b22 Axis under Hypoxia","volume":"8","author":"Liu","year":"2020","journal-title":"PeerJ"},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"2997","DOI":"10.1002\/jcp.27117","article-title":"Long Noncoding RNA MALAT1 Mediates Cardiac Fibrosis in Experimental Postinfarct Myocardium Mice Model","volume":"234","author":"Huang","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s11658-023-00520-2","article-title":"Circular RNA-circPan3 Attenuates Cardiac Hypertrophy via miR-320-3p\/HSP20 Axis","volume":"29","author":"Fang","year":"2024","journal-title":"Cell. Mol. Biol. Lett."},{"key":"ref_217","doi-asserted-by":"crossref","unstructured":"Mens, M.M.J., Maas, S.C.E., Klap, J., Weverling, G.J., Klatser, P., Brakenhoff, J.P.J., van Meurs, J.B.J., Uitterlinden, A.G., Ikram, M.A., and Kavousi, M. (2020). Multi-Omics Analysis Reveals MicroRNAs Associated with Cardiometabolic Traits. Front. Genet., 11.","DOI":"10.3389\/fgene.2020.00110"},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ncrna.2024.09.005","article-title":"Recent Advances in the Development and Clinical Application of miRNAs in Infectious Diseases","volume":"10","author":"Nunes","year":"2024","journal-title":"Non-Coding RNA Res."},{"key":"ref_219","doi-asserted-by":"crossref","unstructured":"Charidemou, E., Felekkis, K., and Papaneophytou, C. (2025). From Natriuretic Peptides to microRNAs: Multi-Analyte Liquid Biopsy Horizons in Heart Failure. Biomolecules, 15.","DOI":"10.3390\/biom15081189"},{"key":"ref_220","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s12079-022-00705-y","article-title":"Advances in Studies of Circulating microRNAs: Origination, Transportation, and Distal Target Regulation","volume":"17","author":"Wu","year":"2023","journal-title":"J. Cell Commun. Signal."},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s11886-023-02014-1","article-title":"MicroRNAs and Cardiovascular Disease Risk","volume":"26","author":"Searles","year":"2024","journal-title":"Curr. Cardiol. Rep."},{"key":"ref_222","doi-asserted-by":"crossref","unstructured":"Hynes, C., and Kakumani, P.K. (2024). Regulatory Role of RNA-Binding Proteins in MicroRNA Biogenesis. Front. Mol. Biosci., 11.","DOI":"10.3389\/fmolb.2024.1374843"},{"key":"ref_223","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1038\/s41574-024-01005-8","article-title":"Circulating Non-Coding RNA Biomarkers of Endocrine Tumours","volume":"20","author":"Butz","year":"2024","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_224","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s41544-019-0039-4","article-title":"Biogenesis and Function of Extracellular miRNAs","volume":"1","author":"Zhao","year":"2019","journal-title":"ExRNA"},{"key":"ref_225","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jare.2023.11.029","article-title":"Exploring the Roles and Molecular Mechanisms of RNA Binding Proteins in the Sorting of Noncoing RNAs into Exosomes during Tumor Progression","volume":"65","author":"Wang","year":"2023","journal-title":"J. Adv. Res."},{"key":"ref_226","doi-asserted-by":"crossref","unstructured":"Gebeyehu, G.M., Rashidiani, S., Farkas, B., Szabadi, A., Brandt, B., Pap, M., and Rauch, T.A. (2024). Unveiling the Role of Exosomes in the Pathophysiology of Sepsis: Insights into Organ Dysfunction and Potential Biomarkers. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25094898"},{"key":"ref_227","doi-asserted-by":"crossref","first-page":"105750","DOI":"10.1016\/j.jbc.2024.105750","article-title":"HuR\u2013miRNA Complex Activates RAS GTPase RalA to Facilitate Endosome Targeting and Extracellular Export of miRNAs","volume":"300","author":"Ghosh","year":"2024","journal-title":"J. Biol. Chem."},{"key":"ref_228","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1038\/s12276-024-01224-z","article-title":"RNA-Binding Proteins and Exoribonucleases Modulating miRNA in Cancer: The Enemy Within","volume":"56","author":"Seo","year":"2024","journal-title":"Exp. Mol. Med."},{"key":"ref_229","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1093\/cvr\/cvr266","article-title":"Profiling of Circulating MicroRNAs: From Single Biomarkers to Re-Wired Networks","volume":"93","author":"Zampetaki","year":"2011","journal-title":"Cardiovasc. Res."},{"key":"ref_230","doi-asserted-by":"crossref","first-page":"109099","DOI":"10.1016\/j.thromres.2024.109099","article-title":"Deciphering the Circulating MicroRNA Signature of Hemophilic Arthropathy","volume":"241","author":"Leuci","year":"2024","journal-title":"Thromb. Res."},{"key":"ref_231","doi-asserted-by":"crossref","first-page":"20354","DOI":"10.1038\/s41598-019-56857-2","article-title":"Analysis of HDL-MicroRNA Panel in Heterozygous Familial Hypercholesterolemia Subjects with LDL Receptor Null or Defective Mutation","volume":"9","author":"Scicali","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_232","doi-asserted-by":"crossref","first-page":"e033674","DOI":"10.1161\/JAHA.123.033674","article-title":"Plasma Extracellular MicroRNAs Associated with Cardiovascular Disease Risk Factors in Middle-Aged and Older Adults","volume":"13","author":"Karlin","year":"2024","journal-title":"J. Am. Heart Assoc."},{"key":"ref_233","doi-asserted-by":"crossref","unstructured":"Han, J., Leppik, L., Sztulman, L., De Rosa, R., Pfeiffer, V., Busse, L.-C., Kontaxi, E., Adam, E., Henrich, D., and Marzi, I. (2025). Dual Roles of Plasma miRNAs in Myocardial Injuries after Polytrauma. Cells, 14.","DOI":"10.3390\/cells14040300"},{"key":"ref_234","doi-asserted-by":"crossref","first-page":"5203","DOI":"10.1039\/D4LC00640B","article-title":"Towards Real-Time Myocardial Infarction Diagnosis: A Convergence of Machine Learning and Ion-Exchange Membrane Technologies Leveraging miRNA Signatures","volume":"24","author":"Ren","year":"2024","journal-title":"Lab Chip"},{"key":"ref_235","doi-asserted-by":"crossref","first-page":"e37793","DOI":"10.1097\/MD.0000000000037793","article-title":"Advances in Research on Biomarkers Associated with Acute Myocardial Infarction: A Review","volume":"103","author":"Huang","year":"2024","journal-title":"Medicine"},{"key":"ref_236","doi-asserted-by":"crossref","unstructured":"Kramna, D., Riedlova, P., and Jirik, V. (2023). MicroRNAs as a Potential Biomarker in the Diagnosis of Cardiovascular Diseases. Medicina, 59.","DOI":"10.3390\/medicina59071329"},{"key":"ref_237","doi-asserted-by":"crossref","first-page":"193","DOI":"10.5937\/jomb0-52617","article-title":"The Diagnostic Value of MicroRNA-499 in Acute Myocardial Infarction: A Systematic Review and Meta-Analysis","volume":"44","author":"Du","year":"2025","journal-title":"J. Med. Biochem."},{"key":"ref_238","doi-asserted-by":"crossref","unstructured":"Iside, C., Picone, F., Di Pietro, P., Abate, A.C., Prete, V., Damato, A., Venturini, E., Akeel, S., Petralia, S., and Vecchione, C. (2025). MicroRNA Signatures in Cardiometabolic Disorders as a Next-Generation Diagnostic Approach. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms262110769"},{"key":"ref_239","doi-asserted-by":"crossref","unstructured":"Fujii, R., Yamada, H., Yamazaki, M., Munetsuna, E., Ando, Y., Ohashi, K., Ishikawa, H., Shimoda, H., Sakata, K., and Ogawa, A. (2019). Circulating MicroRNAs (miR-126, miR-197, and miR-223) Are Associated with Chronic Kidney Disease among Elderly Survivors of the Great East Japan Earthquake. BMC Nephrol., 20.","DOI":"10.1186\/s12882-019-1651-0"},{"key":"ref_240","doi-asserted-by":"crossref","first-page":"8499","DOI":"10.3390\/cimb46080500","article-title":"Diagnostic and Prognostic Role of Circulating MicroRNAs in Patients with Coronary Artery Disease\u2014Impact on Left Ventricle and Arterial Function","volume":"46","author":"Iacobescu","year":"2024","journal-title":"Curr. Issues Mol. Biol."},{"key":"ref_241","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13019-024-03091-1","article-title":"Diagnostic and Prognostic Value of MicroRNA-423-5p in Patients with Heart Failure","volume":"19","author":"Guo","year":"2024","journal-title":"J. Cardiothorac. Surg."},{"key":"ref_242","doi-asserted-by":"crossref","first-page":"104179","DOI":"10.1016\/j.drudis.2024.104179","article-title":"MicroRNAs and Therapeutic Potentials in Acute and Chronic Cardiac Disease","volume":"29","author":"Song","year":"2024","journal-title":"Drug Discov. Today"},{"key":"ref_243","doi-asserted-by":"crossref","unstructured":"Evin, L., Sigutova, R., Sulc, P., Kufova, E., Branny, M., Vaclavik, J., and Stejskal, D. (2025). Serum Levels of miR-21, miR-23a, miR-142-5p, and miR-126 in Chronic Failure with Reduced Ejection Fraction: A Case-Control Study. Front. Cardiovasc. Med., 12.","DOI":"10.3389\/fcvm.2025.1529451"},{"key":"ref_244","doi-asserted-by":"crossref","unstructured":"Cordeiro, M.A., de Carvalho, A.E.T.S., and Spadari, R.C. (2025). MicroRNAs\u2019 Impact on Heart Diseases. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26125566"},{"key":"ref_245","doi-asserted-by":"crossref","first-page":"C367","DOI":"10.1152\/ajpcell.00051.2022","article-title":"The MicroRNA-29 Family: Role in Metabolism and Metabolic Disease","volume":"323","author":"Dalgaard","year":"2022","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"ref_246","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s44385-025-00030-0","article-title":"Exosomes: Bridge Metabolic Regulation in Cardiac Repair","volume":"2","author":"Mao","year":"2025","journal-title":"npj Biomed. Innov."},{"key":"ref_247","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.bbrc.2009.08.136","article-title":"MicroRNA-133 Regulates the Expression of GLUT4 by Targeting KLF15 and Is Involved in Metabolic Control in Cardiac Myocytes","volume":"389","author":"Horie","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_248","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1093\/clinchem\/hvab030","article-title":"Circulating MicroRNA-210 Concentrations in Patients with Acute Heart Failure","volume":"67","author":"Rutkovskiy","year":"2021","journal-title":"Clin. Chem."},{"key":"ref_249","doi-asserted-by":"crossref","first-page":"452","DOI":"10.15836\/ccar2024.452","article-title":"MicroRNAs as Potential Biomarkers of Heart Failure","volume":"19","author":"Gjuras","year":"2024","journal-title":"Cardiol. Croat."},{"key":"ref_250","doi-asserted-by":"crossref","first-page":"5003","DOI":"10.1073\/pnas.1019055108","article-title":"Argonaute2 Complexes Carry a Population of Circulating MicroRNAs Independent of Vesicles in Human Plasma","volume":"108","author":"Arroyo","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_251","doi-asserted-by":"crossref","first-page":"e37929","DOI":"10.1016\/j.heliyon.2024.e37929","article-title":"Potential Diagnostic Value of Circulating miRNAs in HFrEF and Bioinformatics Analysis","volume":"10","author":"Kuai","year":"2024","journal-title":"Heliyon"},{"key":"ref_252","doi-asserted-by":"crossref","unstructured":"Sigutova, R., Evin, L., Kusnierova, P., Stejskal, D., Vsiansky, F., Bace, E., Kufova, E., Kubikova, G., Svagera, Z., and Branny, M. (2025). Specific MicroRNAs for Heart Failure: Reference Values in Whole Blood. Biomedicines, 13.","DOI":"10.3390\/biomedicines13102559"},{"key":"ref_253","doi-asserted-by":"crossref","first-page":"e27206","DOI":"10.1016\/j.heliyon.2024.e27206","article-title":"Profile of Serum MicroRNAs in Heart Failure with Reduced and Preserved Ejection Fraction","volume":"10","author":"Paim","year":"2024","journal-title":"Heliyon"},{"key":"ref_254","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.repc.2021.03.020","article-title":"Candidate MicroRNAs as Prognostic Biomarkers in Heart Failure: A Systematic Review","volume":"41","author":"Figueiredo","year":"2022","journal-title":"Rev. Port. Cardiol."},{"key":"ref_255","first-page":"4736","article-title":"Plasma Levels of MicroRNA-21, -126 and -423-5p Alter during Clinical Improvement and Are Associated with the Prognosis of Acute Heart Failure","volume":"17","author":"Schneider","year":"2018","journal-title":"Mol. Med. Rep."},{"key":"ref_256","doi-asserted-by":"crossref","unstructured":"Huang, J.-P., Chang, C.-C., Kuo, C.-Y., Huang, K.-J., Sokal, E.M., Chen, K.-H., and Hung, L.-M. (2022). Exosomal MicroRNAs miR-30d-5p and miR-126a-5p Are Associated with Heart Failure with Preserved Ejection Fraction in STZ-Induced Type 1 Diabetic Rats. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23147514"},{"key":"ref_257","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ejim.2025.03.022","article-title":"Association of miR-126-3p, miR-1260b and miR-374a-5p with the Incidence of Heart Failure in a Population-Based Cohort: The Hortega Follow-Up Study","volume":"135","author":"Alonso","year":"2025","journal-title":"Eur. J. Intern. Med."},{"key":"ref_258","doi-asserted-by":"crossref","unstructured":"Boichenko, V., Noakes, V.M., Reilly-O\u2019Donnell, B., Luciani, G.B., Emanueli, C., Martelli, F., and Gorelik, J. (2025). Circulating Non-Coding RNAs as Indicators of Fibrosis and Heart Failure Severity. Cells, 14.","DOI":"10.3390\/cells14070553"},{"key":"ref_259","doi-asserted-by":"crossref","first-page":"3397","DOI":"10.2147\/IJGM.S316285","article-title":"MicroRNA-126 Level Increases during Exercise Rehabilitation of Heart Failure with a Preserved Ejection Fraction","volume":"14","author":"Jin","year":"2021","journal-title":"Int. J. Gen. Med."},{"key":"ref_260","doi-asserted-by":"crossref","unstructured":"Chen, J., Xiao, X., Zhou, C., Zhang, Y., Rhee, J., and Li, H. (2025). The Dark Side of Vascular Aging: Noncoding Ribonucleic Acids in Heart Failure with Preserved Ejection Fraction. Cells, 14.","DOI":"10.3390\/cells14161269"},{"key":"ref_261","doi-asserted-by":"crossref","unstructured":"Brioschi, M., D\u2019Alessandra, Y., Mapelli, M., Mattavelli, I., Salvioni, E., Eligini, S., Mallia, A., Ricci, V., Gianazza, E., and Ghilardi, S. (2023). Impact of Sacubitril\/Valsartan on Circulating MicroRNA in Patients with Heart Failure. Biomedicines, 11.","DOI":"10.3390\/biomedicines11041037"},{"key":"ref_262","doi-asserted-by":"crossref","unstructured":"Moscoso, I., Cebro-M\u00e1rquez, M., Mart\u00ednez-G\u00f3mez, \u00c1., Abou-Jokh, C., Mart\u00ednez-Monzon\u00eds, M.A., Mart\u00ednez-Sande, J.L., Gonz\u00e1lez-Melchor, L., Garc\u00eda-Seara, J., Fern\u00e1ndez-L\u00f3pez, X.A., and Mora\u00f1a-Fern\u00e1ndez, S. (2022). Circulating miR-499a and miR-125b as Potential Predictors of Left Ventricular Ejection Fraction Improvement after Cardiac Resynchronization Therapy. Cells, 11.","DOI":"10.3390\/cells11020271"},{"key":"ref_263","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1186\/s12967-023-04558-w","article-title":"Circulating miR-133a-3p Defines a Low-Risk Subphenotype in Patients with Heart Failure and Central Sleep Apnea: A Decision Tree Machine Learning Approach","volume":"21","author":"Belmonte","year":"2023","journal-title":"J. Transl. Med."},{"key":"ref_264","doi-asserted-by":"crossref","first-page":"3367","DOI":"10.1002\/ehf2.13919","article-title":"Serum MicroRNAs Are Key Predictors of Long-Term Heart Failure and Cardiovascular Death after Myocardial Infarction","volume":"9","author":"Conde","year":"2022","journal-title":"ESC Heart Fail."},{"key":"ref_265","first-page":"17","article-title":"Diagnostic and Prognostic Relevance of Circulating MicroRNAs in Heart Failure","volume":"3","author":"Vasu","year":"2025","journal-title":"Heart Fail. J. India"},{"key":"ref_266","doi-asserted-by":"crossref","unstructured":"Felekkis, K., and Papaneophytou, C. (2024). The Circulating Biomarkers League: Combining miRNAs with Cell-Free DNAs and Proteins. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25063403"},{"key":"ref_267","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1161\/CIRCRESAHA.111.247452","article-title":"Circulating MicroRNAs: Novel Biomarkers and Extracellular Communicators in Cardiovascular Disease?","volume":"110","author":"Creemers","year":"2012","journal-title":"Circ. Res."},{"key":"ref_268","doi-asserted-by":"crossref","unstructured":"Condrat, C.E., Thompson, D.C., Barbu, M.G., Bugnar, O.L., Boboc, A., Cretoiu, D., Suciu, N., Cretoiu, S.M., and Voinea, S.C. (2020). miRNAs as Biomarkers in Disease: Latest Findings Regarding Their Role in Diagnosis and Prognosis. Cells, 9.","DOI":"10.3390\/cells9020276"},{"key":"ref_269","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/ejhf.2333","article-title":"2021 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure","volume":"24","author":"McDonagh","year":"2022","journal-title":"Eur. J. Heart Fail."},{"key":"ref_270","doi-asserted-by":"crossref","first-page":"e618","DOI":"10.1161\/CIR.0000000000000617","article-title":"Fourth Universal Definition of Myocardial Infarction (2018)","volume":"138","author":"Thygesen","year":"2018","journal-title":"Circulation"},{"key":"ref_271","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1002\/ejhf.2700","article-title":"Diagnostic Performance of MicroRNAs in the Detection of Heart Failure with Reduced or Preserved Ejection Fraction: A Systematic Review and Meta-Analysis","volume":"24","author":"Parvan","year":"2022","journal-title":"Eur. J. Heart Fail."},{"key":"ref_272","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1161\/CIRCRESAHA.110.218297","article-title":"miR-423-5p as a Circulating Biomarker for Heart Failure","volume":"106","author":"Tijsen","year":"2010","journal-title":"Circ. Res."},{"key":"ref_273","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1002\/ehf2.14649","article-title":"MicroRNAs Are Associated with Cardiac Biomarkers, Cardiac Structure and Function and Incident Outcomes in Heart Failure","volume":"11","author":"Spahillari","year":"2024","journal-title":"ESC Heart Fail."},{"key":"ref_274","doi-asserted-by":"crossref","unstructured":"Micu, M.A., Cozac, D.A., and Scridon, A. (2025). miRNA-Orchestrated Fibroinflammatory Responses in Heart Failure with Preserved Ejection Fraction: Translational Opportunities for Precision Medicine. Diagnostics, 15.","DOI":"10.3390\/diagnostics15182286"},{"key":"ref_275","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1016\/j.jacbts.2023.09.006","article-title":"Development of a Mechanism-Based Next-Generation Therapeutic for Heart Failure Derived from the Dark Genome","volume":"8","author":"Viereck","year":"2023","journal-title":"JACC Basic Transl. Sci."},{"key":"ref_276","doi-asserted-by":"crossref","first-page":"qyaf088","DOI":"10.1093\/ehjimp\/qyaf088","article-title":"miR-132 Inhibition Improves Myocardial Strain in a Large Animal Model of Chronic Left Ventricular Adverse Remodelling","volume":"3","author":"Batkai","year":"2025","journal-title":"Eur. Heart J. Imaging Methods Pract."},{"key":"ref_277","doi-asserted-by":"crossref","unstructured":"Seyhan, A.A. (2024). Trials and Tribulations of MicroRNA Therapeutics. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25031469"},{"key":"ref_278","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s13046-025-03391-x","article-title":"MicroRNA in Cancer Therapy: Breakthroughs and Challenges in Early Clinical Applications","volume":"44","author":"Martino","year":"2025","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_279","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1177\/21593337251387423","article-title":"Immunogenicity Risk Assessment for Nucleic Acid Therapeutics: A Comprehensive Evaluation for ASO, siRNA, and Nonvaccine mRNA\/LNP Therapies by the IQ Consortium","volume":"35","author":"Braun","year":"2025","journal-title":"Nucleic Acid Ther."},{"key":"ref_280","doi-asserted-by":"crossref","unstructured":"Nappi, F. (2024). Non-Coding RNA-Targeted Therapy: A State-of-the-Art Review. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25073630"},{"key":"ref_281","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/FJC.0000000000001729","article-title":"miR-132 Inhibition Improves Cardiac Remodeling and Function in a Two-Hit Mouse Model of Heart Failure with a Preserved Ejection Fraction","volume":"86","author":"Wu","year":"2025","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"ref_282","doi-asserted-by":"crossref","first-page":"BSR20201696","DOI":"10.1042\/BSR20201696","article-title":"MicroRNA-132 Attenuated Cardiac Fibrosis in Myocardial Infarction-Induced Heart Failure Rats","volume":"40","author":"Wang","year":"2020","journal-title":"Biosci. Rep."},{"key":"ref_283","doi-asserted-by":"crossref","unstructured":"Mao, H., Hu, J., Yu, C., Xie, S., Chang, C., Peng, J., and Zhang, Y. (2025). MicroRNAs in Anthracycline Cardiotoxicity: Biomarkers, Mechanisms, and Therapeutic Advances. Front. Cardiovasc. Med., 12.","DOI":"10.3389\/fcvm.2025.1614878"},{"key":"ref_284","doi-asserted-by":"crossref","unstructured":"Yuan, S., Ye, Q., and Qin, R. (2025). Cardioepigenetics in Action: Aerobic Exercise-Induced Modulation of miRNAs, lncRNAs, and Chromatin Remodeling in Cardiovascular Disease. Front. Cardiovasc. Med., 12.","DOI":"10.3389\/fcvm.2025.1579352"},{"key":"ref_285","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/s41392-025-02312-w","article-title":"Extracellular Vesicle-Based Drug Overview: Research Landscape, Quality Control and Nonclinical Evaluation Strategies","volume":"10","author":"Xu","year":"2025","journal-title":"Sig. Transduct. Target Ther."},{"key":"ref_286","doi-asserted-by":"crossref","unstructured":"Liang, R., Abudurexiti, N., Wu, J., Ling, J., Peng, Z., Yuan, H., and Wen, S. (2024). Exosomes and miRNAs in Cardiovascular Diseases and Transcatheter Pulmonary Valve Replacement: Advancements, Gaps and Perspectives. Int. J. Mol. Sci., 25.","DOI":"10.20944\/preprints202411.0806.v1"},{"key":"ref_287","doi-asserted-by":"crossref","first-page":"e159179","DOI":"10.1172\/JCI159179","article-title":"MicroRNAs as Therapeutic Targets in Cardiovascular Disease","volume":"132","author":"Laggerbauer","year":"2022","journal-title":"J. Clin. Investig."},{"key":"ref_288","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s12933-021-01245-2","article-title":"MicroRNAs and Long Non-Coding RNAs in the Pathophysiological Processes of Diabetic Cardiomyopathy: Emerging Biomarkers and Potential Therapeutics","volume":"20","author":"Jakubik","year":"2021","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_289","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/ejhf.984","article-title":"Prognostic Value of Circulating MicroRNAs on Heart Failure-Related Morbidity and Mortality in Two Large Diverse Cohorts of General Heart Failure Patients","volume":"20","author":"Lanfear","year":"2018","journal-title":"Eur. J. Heart Fail."},{"key":"ref_290","doi-asserted-by":"crossref","first-page":"154853","DOI":"10.1016\/j.prp.2023.154853","article-title":"MicroRNAs and Cardiac Fibrosis: A Comprehensive Update on Mechanisms and Consequences","volume":"251","author":"Gocer","year":"2023","journal-title":"Pathol. Res. Pract."},{"key":"ref_291","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1093\/eurheartj\/ehae102","article-title":"Inhibition of miR-21: Cardioprotective Effects in Human Failing Myocardium ex vivo","volume":"45","author":"Abbas","year":"2024","journal-title":"Eur. Heart J."},{"key":"ref_292","doi-asserted-by":"crossref","unstructured":"Bernardo, B.C., Yildiz, G.S., Kiriazis, H., Harmawan, C.A., Tai, C.M.K., Ritchie, R.H., and McMullen, J.R. (2022). In Vivo Inhibition of miR-34a Modestly Limits Cardiac Enlargement and Fibrosis in a Mouse Model with Established Type 1 Diabetes-Induced Cardiomyopathy, but Does Not Improve Diastolic Function. Cells, 11.","DOI":"10.3390\/cells11193117"},{"key":"ref_293","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s10557-020-06968-0","article-title":"Dihydromyricetin Prevents Diabetic Cardiomyopathy via miR-34a Suppression by Activating Autophagy","volume":"34","author":"Ni","year":"2020","journal-title":"Cardiovasc. Drugs Ther."},{"key":"ref_294","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1093\/eurheartj\/ehp573","article-title":"MicroRNAs in Heart Disease: Putative Novel Therapeutic Targets?","volume":"31","author":"Condorelli","year":"2010","journal-title":"Eur. Heart J."},{"key":"ref_295","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.1016\/j.jacc.2021.04.028","article-title":"AntimiR-132 Attenuates Myocardial Hypertrophy in an Animal Model of Percutaneous Aortic Constriction","volume":"77","author":"Hinkel","year":"2021","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_296","doi-asserted-by":"crossref","unstructured":"Zhang, H., Wang, L., Yin, D., Zhou, Q., Lv, L., Dong, Z., and Shi, Y. (2022). Integration of Proteomic and Metabolomic Characterization in Atrial Fibrillation-Induced Heart Failure. BMC Genom., 23.","DOI":"10.1186\/s12864-022-09044-z"},{"key":"ref_297","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/s13073-024-01395-4","article-title":"Integrating Metabolomics and Proteomics to Identify Novel Drug Targets for Heart Failure and Atrial Fibrillation","volume":"16","author":"Finan","year":"2024","journal-title":"Genome Med."},{"key":"ref_298","doi-asserted-by":"crossref","unstructured":"Abudurexiti, M., Abuduhalike, R., Naman, T., Wupuer, N., Duan, D., Keranmu, M., and Mahemuti, A. (2024). Integrated Proteomic and Metabolomic Profiling Reveals Novel Insights on the Inflammation and Immune Response in HFpEF. BMC Genom., 25.","DOI":"10.1186\/s12864-024-10575-w"},{"key":"ref_299","doi-asserted-by":"crossref","unstructured":"Chaanine, A.H., Higgins, L., Markowski, T., Harman, J., Kachman, M., Burant, C., Navar, L.G., Busija, D., and Delafontaine, P. (2022). Multi-Omics Approach Profiling Metabolic Remodeling in Early Systolic Dysfunction and in Overt Systolic Heart Failure. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23010235"},{"key":"ref_300","doi-asserted-by":"crossref","unstructured":"Aharon-Yariv, A., Wang, Y., Ahmed, A., and Delgado-Olgu\u00edn, P. (2023). Integrated Small RNA, mRNA and Protein Omics Reveal a miRNA Network Orchestrating Metabolic Maturation of the Developing Human Heart. BMC Genom., 24.","DOI":"10.1186\/s12864-023-09801-8"},{"key":"ref_301","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.2174\/0113862073316437240426071022","article-title":"miRNAs Influence m6A RNA Methylation through FTO and IGF2BP2 in Pressure Overload-Induced Heart Failure","volume":"28","author":"Wang","year":"2025","journal-title":"Comb. Chem. High Throughput Screen."},{"key":"ref_302","doi-asserted-by":"crossref","first-page":"4908","DOI":"10.7150\/ijbs.95707","article-title":"METTL3-Mediated m6A Modification of OTUD1 Aggravates Pressure Overload-Induced Myocardial Hypertrophy by Deubiquitinating PGAM5","volume":"20","author":"Huang","year":"2024","journal-title":"Int. J. Biol. Sci."},{"key":"ref_303","doi-asserted-by":"crossref","first-page":"110524","DOI":"10.1016\/j.isci.2024.110524","article-title":"The Potential of RNA Methylation in the Treatment of Cardiovascular Diseases","volume":"27","author":"Wang","year":"2024","journal-title":"iScience"},{"key":"ref_304","doi-asserted-by":"crossref","unstructured":"Vilella-Figuerola, A., Gallinat, A., Escate, R., Mirabet, S., Padr\u00f3, T., and Badimon, L. (2022). Systems Biology in Chronic Heart Failure\u2014Identification of Potential miRNA Regulators. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms232315226"},{"key":"ref_305","doi-asserted-by":"crossref","unstructured":"Xiong, T., Li, Q., Wang, Y., Kong, Y., Li, H., Liu, J., Wu, Y., and Zhang, F. (2024). Integrated Multi-Omics Analysis Describes Immune Profiles in Ischemic Heart Failure and Identifies PTN as a Novel Biomarker. Front. Mol. Biosci., 11.","DOI":"10.3389\/fmolb.2024.1524827"},{"key":"ref_306","doi-asserted-by":"crossref","first-page":"RP89701","DOI":"10.7554\/eLife.89701","article-title":"Systems Analysis of miR-199a\/b-5p and Multiple miR-199a\/b-5p Targets during Chondrogenesis","volume":"12","author":"Patel","year":"2024","journal-title":"eLife"},{"key":"ref_307","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1007\/s00395-024-01074-w","article-title":"Single-Cell Transcriptomics Reveal Distinctive Patterns of Fibroblast Activation in Heart Failure with Preserved Ejection Fraction","volume":"119","author":"Lanzer","year":"2024","journal-title":"Basic Res. Cardiol."},{"key":"ref_308","doi-asserted-by":"crossref","unstructured":"Ahmed, Z., Wan, S., Zhang, F., and Zhong, W. (2024). Artificial Intelligence for Omics Data Analysis. BMC Methods, 1.","DOI":"10.1186\/s44330-024-00004-5"},{"key":"ref_309","doi-asserted-by":"crossref","unstructured":"Flores, J.E., Claborne, D.M., Weller, Z.D., Webb-Robertson, B.M., Waters, K.M., and Bramer, L.M. (2023). Missing Data in Multi-Omics Integration: Recent Advances through Artificial Intelligence. Front. Artif. Intell., 6.","DOI":"10.3389\/frai.2023.1098308"},{"key":"ref_310","doi-asserted-by":"crossref","unstructured":"Jeong, Y., Ronen, J., Kopp, W., Lutsik, P., and Akalin, A. (2024). scMaui: A Widely Applicable Deep Learning Framework for Single-Cell Multiomics Integration in the Presence of Batch Effects and Missing Data. BMC Bioinform., 25.","DOI":"10.1186\/s12859-024-05880-w"},{"key":"ref_311","doi-asserted-by":"crossref","unstructured":"Lin, Z., Yang, T., Chen, D., Zhang, P., Luo, J., Chen, S., Gu, S., Shen, Y., Tang, T., and Chang, T. (2025). Integrating Machine Learning and Multi-Omics to Explore Neutrophil Heterogeneity. Biomedicines, 13.","DOI":"10.3390\/biomedicines13092171"},{"key":"ref_312","doi-asserted-by":"crossref","unstructured":"Contreras-Rodr\u00edguez, J.A., C\u00f3rdova-Esparza, D.M., Saavedra-Leos, M.Z., and Silva-C\u00e1zares, M.B. (2023). Machine Learning and miRNAs as Potential Biomarkers of Breast Cancer: A Systematic Review of Classification Methods. Appl. Sci., 13.","DOI":"10.3390\/app13148257"},{"key":"ref_313","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s12032-024-02579-z","article-title":"Advancing miRNA Cancer Research through Artificial Intelligence: From Biomarker Discovery to Therapeutic Targeting","volume":"42","author":"Aswathy","year":"2024","journal-title":"Med. Oncol."},{"key":"ref_314","doi-asserted-by":"crossref","unstructured":"Pagoni, M., Cava, C., Sideris, D.C., Avgeris, M., Zoumpourlis, V., Michalopoulos, I., and Drakoulis, N. (2023). miRNA-Based Technologies in Cancer Therapy. J. Pers. Med., 13.","DOI":"10.3390\/jpm13111586"},{"key":"ref_315","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.7150\/ijms.102123","article-title":"Decoding the Promise and Challenges of miRNA-Based Cancer Therapies: An Essential Update on miR-21, miR-34, and miR-155","volume":"21","author":"Qian","year":"2024","journal-title":"Int. J. Med. Sci."},{"key":"ref_316","first-page":"265","article-title":"MicroRNA Bioinformatics in Precision Oncology: An Integrated Pipeline from NGS to AI-Based Target Discovery","volume":"66","author":"Dey","year":"2025","journal-title":"J. Appl. Genet."},{"key":"ref_317","doi-asserted-by":"crossref","first-page":"11","DOI":"10.36628\/ijhf.2023.0050","article-title":"Application and Potential of Artificial Intelligence in Heart Failure: Past, Present, and Future","volume":"6","author":"Yoon","year":"2023","journal-title":"Int. J. Heart Fail."},{"key":"ref_318","doi-asserted-by":"crossref","first-page":"2907","DOI":"10.1002\/ehf2.13371","article-title":"Identification of Novel Circulating MicroRNAs in Advanced Heart Failure by Next-Generation Sequencing","volume":"8","author":"Galluzzo","year":"2021","journal-title":"ESC Heart Fail."},{"key":"ref_319","doi-asserted-by":"crossref","first-page":"13896","DOI":"10.1038\/s41598-024-64732-y","article-title":"Regulatory Network Analysis Based on Integrated miRNA\u2013TF Reveals Key Genes in Heart Failure","volume":"14","author":"Zhang","year":"2024","journal-title":"Sci. Rep."},{"key":"ref_320","doi-asserted-by":"crossref","first-page":"ehae666.769","DOI":"10.1093\/eurheartj\/ehae666.769","article-title":"Identification and Validation of Circulating MicroRNAs as Biomarkers for Heart Failure with Preserved Ejection Fraction","volume":"45","author":"Zhang","year":"2024","journal-title":"Eur. Heart J."},{"key":"ref_321","doi-asserted-by":"crossref","unstructured":"Charrier, H., Cuvelliez, M., Dubois-Deruy, E., Mulder, P., Richard, V., Bauters, C., and Pinet, F. (2019). Integrative System Biology Analyses Identify Seven MicroRNAs to Predict Heart Failure. Non-Coding RNA, 5.","DOI":"10.20944\/preprints201902.0030.v1"},{"key":"ref_322","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1007\/s10741-020-10071-9","article-title":"A Meta-Analysis of MicroRNA Expression Profiling Studies in Heart Failure","volume":"26","author":"Gholaminejad","year":"2021","journal-title":"Heart Fail. Rev."},{"key":"ref_323","doi-asserted-by":"crossref","unstructured":"Han, Q., Zhang, L., and Liao, R. (2024). Diagnostic and Prognostic Significance of miR-320a-3p in Patients with Chronic Heart Failure. BMC Cardiovasc. Disord., 24.","DOI":"10.1186\/s12872-024-03966-0"},{"key":"ref_324","first-page":"209","article-title":"Circulating MicroRNAs as Novel Biomarkers for Heart Failure","volume":"59","author":"Chen","year":"2018","journal-title":"Hell. J. Cardiol."}],"container-title":["Life"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-1729\/16\/3\/400\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T16:27:18Z","timestamp":1772468838000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-1729\/16\/3\/400"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,1]]},"references-count":324,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,3]]}},"alternative-id":["life16030400"],"URL":"https:\/\/doi.org\/10.3390\/life16030400","relation":{},"ISSN":["2075-1729"],"issn-type":[{"value":"2075-1729","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,1]]}}}